JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.


*610 !**	Thu, 8/4/2011, 8:30 AM - 10:20 AM	CC-D231/232
Issues of Biomarker Testing in Clinical Trials for Personalized Medicine — Topic Contributed Papers
Biopharmaceutical Section , WNAR , Scientific and Public Affairs Advisory Committee
Organizer(s): Sue-Jane Wang, U.S. Food and Drug Administration/CDER
Chair(s): Mingxiu Hu, Millennium: The Takeda Oncology Company
8:35 AM	Testing for broad efficacy and efficacy in genomic subgroups using partitioning principle — Szu-Yu Tang, The Ohio State University ; Yi Liu, Millennium: The Takeda Oncology Company ; Jason C. Hsu, The Ohio State University
8:55 AM	The Relationship Between CYP2C19 Genetic Polymorphisms, Clopidogrel Treatment, and Clinical Outcomes — Katy Simonsen, Bristol-Myers Squibb ; Oksana Mokliatchouk, Bristol-Myers Squibb ; Eileen Emison, Bristol-Myers Squibb
9:15 AM	Biomarker Identification and Patient Condition Prediction Based on Gene-Expression Pattern from Two Case Studies — Yushi Liu, The Lovelace Respiratory Research Institute ; Joe Verducci, The Ohio State University
9:35 AM	Model Selection v. Multiple Testing in Genome-Wide Association Studies — Florian Frommlet, Medical University Vienna ; Felix Ruhaltinger, Medical University Vienna ; Malgorzata Bogdan, TU Wroclaw
9:55 AM	Exploring potential early predictors of clinical response to Yervoy immunotherapy — Scott Chasalow, Bristol-Myers Squibb ; Daniel Brickman, Bristol-Myers Squibb
10:15 AM	Floor Discussion

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.